Measurements of Complement Factor H-Related Protein (BTA-TRAK™ Assay) and Nuclear Matrix Protein (NMP22 Assay) – Useful Diagnostic Tools in the Diagnosis of Urinary Bladder Cancer?-Reference-Cited by-同舟云学术

Measurements of Complement Factor H-Related Protein (BTA-TRAK™ Assay) and Nuclear Matrix Protein (NMP22 Assay) – Useful Diagnostic Tools in the Diagnosis of Urinary Bladder Cancer?

Published:2003-01-27 Issue:1 Volume:41 Page:
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine
language:
Short-container-title:

Author:

Mahnert Brigitte,Tauber Stephan,Kriegmair Martin,Nagel Dorothea,Holdenrieder Stefan,Hofmann Karin,Reiter Wolfgang,Schmeller Nikolaus,Stieber Petra

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry, medical,Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/CCLM.2003.018/pdf

Reference14 articles.

1. Factors Influencing the Recurrence Rate of Bladder Cancer

2. Results of bard bta test in monitoring patients with a history of transitional cell cancer of the bladder

3. SCREENING AND MONITORING FOR BLADDER CANCER: REFINING THE USE OF NMP22

4. Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Biosensors in Bladder Cancer;Critical Reviews in Analytical Chemistry;2024-07-08

2. Off the fog to find the optimal choice: Research advances in biomarkers for early diagnosis and recurrence monitoring of bladder cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

3. Higher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study;Archivos Españoles de Urología;2023

4. Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental Model;Diagnostics;2021-06-03

5. Bladder tumor antigen;Springer Reference Medizin;2019